98%
921
2 minutes
20
Patients undergoing dialysis through a permanent catheter often experience infection or malfunction. However, few studies have clarified the predictors of permanent catheter patency survival in patients undergoing hemodialysis. We assessed the relationship between the parameters of body composition monitoring (BCM), determined before the initiation of dialysis, and the patency survival of the permanent catheters inserted in 179 patients who commenced hemodialysis between 14 January 2020 and 31 August 2021. The relationships between permanent catheter patency at 6 weeks and BCM parameters, laboratory tests, age, sex, comorbidities, and medications at baseline were studied using Kaplan-Meier survival curves. Permanent catheter patency was observed to be superior at high extracellular-to-intracellular (ECW/ICW) ratio ( < 0.005). After adjustment for covariates, the ECW/ICW ratio remained an independent factor associated with permanent catheter patency survival. When patients with non-patent catheters were subdivided into infection and malfunction groups, and the associations of BCM parameters were evaluated in those groups, the ECW/ICW ratio was not significantly associated with permanent catheter patency survival in the infection group ( = 0.327); instead, a significant association was found for the lean tissue index ( < 0.001). In the malfunction group, the ECW/ICW ratio remained significantly associated with permanent catheter patency survival ( < 0.001).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417513 | PMC |
http://dx.doi.org/10.3390/diagnostics13152545 | DOI Listing |
Catheter Cardiovasc Interv
September 2025
Department of Cardiology, Barts Heart Center, Barts Health NHS Trust, London, UK.
Background: Degeneration of surgical bioprosthetic aortic valves is increasingly common. Redo surgical aortic valve replacement carries substantial morbidity and mortality, particularly in elderly or high-risk patients. Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) has become an established alternative, though data on the performance of self-expanding Portico and Navitor valves remain limited.
View Article and Find Full Text PDFAnn Vasc Surg
September 2025
Interventional Radiology, Cleveland Clinic, Cleveland, OH, USA. Electronic address:
Objectives: As a two-dimensional modality, venography has limitations in its capacity to measure lumen caliber and to assess stenotic disease accurately. This has implications in the management of end-stage renal-disease (ESRD) patients "no-option" candidates access for arteriovenous fistula (AVF) or graft (AVG) creation secondary to high risk of vascular access failure. The incremental diagnostic and clinical impact of intravascular ultrasound (IVUS) was quantified in this tunneled dialysis catheter dependent ESRD cohort.
View Article and Find Full Text PDFJ Infus Nurs
September 2025
Author Affiliations: Department of Nursing, Federal University of Rio Grande do Norte, Natal, Brazil (Lima, Sena, Bispo, Chagas, Ribeiro, and de Oliveira Araújo).
Objective: The aim of this study was to map nursing care in the treatment of lesions due to vasoactive drug extravasation. This scoping review is built according to the recommendations of the Joanna Briggs Institute and PRISMA-ScR.
Methods: The review was carried out from July to August 2022, across 12 data sources.
Perit Dial Int
September 2025
Division of Nephrology, Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China.
(MTB)-related peritonitis is a rare but serious complication in patients receiving maintenance peritoneal dialysis (PD). Early diagnosis is difficult due to the low sensitivity and delayed results of conventional microscopy and culture methods. MTB polymerase chain reaction (PCR) testing in PD effluent is recommended as a diagnostic adjunct, but real-world data remain limited.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
September 2025
Department of Internal Medicine, Division of Cardiology, Hennepin Healthcare, Minneapolis, Minnesota, USA.
Background: Existing literature highlights unfavorable outcomes for patients with cardiac conduction disorders and Pulmonary Hypertension (PH). However, limited data exist on complete heart block (CHB) outcomes in the context of group 2 PH.
Aims: To utilize a large national inpatient dataset to evaluate the association between group 2 PH and hospitalization outcomes in patients with CHB.